Literature DB >> 6413108

Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.

T H Bacon, A de Vere-Tyndall, D A Tyrrell, A M Denman, B M Ansell.   

Abstract

Eighteen patients with active systemic juvenile chronic arthritis (JCA) were studied for periods of up to 1 year to see whether any relationships existed between the interferon (IFN) response, the course of the underlying disease and intercurrent infections. The control group consisted of 23 children who were each seen on one occasion. IFN-alpha production by mononuclear cells (MNC) cultured in vitro was stimulated with Newcastle disease virus (NDV). Comparison of the mean IFN-alpha responses from all patients with control responses showed that MNC from the JCA group produced significantly more IFN-alpha. Furthermore, MNC obtained from JCA patients at times of systemic flare produced significantly higher titres of IFN-alpha than at times when the patients were clinically stable. IFN-alpha production by MNC from individual patients fluctuated considerably from occasion to occasion whereas IFN-gamma production by MNC induced with phytohaemagglutinin (PHA) remained more stable. There was no significant difference between patients and controls with respect to IFN-gamma responses and no relationship with clinical condition. Serum IFN was not detected either by sensitive bioassays for IFN-alpha and IFN-gamma or by an immunoradiometric assay for IFN-alpha.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413108      PMCID: PMC1536204     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I)-poly(C) and human interferon.

Authors:  M Yaron; I Yaron; D Gurari-Rotman; M Revel; H R Lindner; U Zor
Journal:  Nature       Date:  1977-06-02       Impact factor: 49.962

Review 2.  Prostaglandins and chronic inflammation.

Authors:  I L Bonta; M J Parnham
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

3.  Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

Authors:  H Strander; K Cantell; G Carlström; P A Jakobsson
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

4.  A rapid and simple method for assaying interferon.

Authors:  J Suzuki; T Akaboshi; S Kobayashi
Journal:  Jpn J Microbiol       Date:  1974-11

5.  Heberden Oration, 1977. Chronic arthritis in childhood.

Authors:  B M Ansell
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

6.  Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture.

Authors:  J Farrant; J C Clark; H Lee; S C Knight; J O'Brien
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Optimization of the interferon assay using inhibition of Semliki forest virus-ribonucleic acid synthesis.

Authors:  H Koblet; U Kohler; R Wyler
Journal:  Appl Microbiol       Date:  1972-09

8.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

9.  Detection of gamma interferon in the sera of patients with Behçet's disease.

Authors:  S Ohno; F Kato; H Matsuda; N Fujii; T Minagawa
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.

Authors:  A D Steinberg; S Baron; N Talal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

View more
  10 in total

1.  Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma-interferon.

Authors:  M G Ridley; G S Panayi; N S Nicholas; J Murphy
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

2.  Changes in the populations of lymphoid cells in human peripheral blood following physical exercise.

Authors:  A J Edwards; T H Bacon; C A Elms; R Verardi; M Felder; S C Knight
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

3.  Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages.

Authors:  R Zawatzky; H Wurmbaeck; W Falk; A Homfeld
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.

Authors:  P J Guillou; G R Giles; C W Ramsden
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

5.  Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.

Authors:  T H Bacon; F Ozbakir; C A Elms; A M Denman
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

6.  Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Elizabeth Wong; Yujuan Zhang; Khoa D Nguyen; Justin Lee; Diana Milojevic; Susan Shenoi; Anne M Stevens; Norman Ilowite; Vivian Saper; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2015-12-31       Impact factor: 3.969

7.  Anaemia in juvenile chronic arthritis: serum inhibition of normal erythropoiesis in vitro.

Authors:  P J Prouse; A R Harvey; B Bonner; C D Reid; B M Ansell; M Gumpel
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

8.  Serum interferon activity in inflammatory bowel disease. Arachidonic acid release and lipoxygenation activated by alpha-class interferon in human neutrophils.

Authors:  O H Nielsen; J Elmgreen; I Ahnfelt-Rønne
Journal:  Inflammation       Date:  1988-04       Impact factor: 4.092

9.  Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.

Authors:  K Müller; F K Pedersen; A Wiik; K Bendtzen
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

10.  Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies.

Authors:  Wahid Ali Khan
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.